Published :
Tables : 19
Figures : 31
Category : Healthcare
No. of Pages : 200
Report Code : HC-1004
Pre-Filled Auto Injectors Market Introduction Pre-filled auto-injectors are defined as unit dose medication for parenteral administration. Pre-filled auto-injectors are intended for self-administration by patients. Pre-filled auto-injectors are mostly spring-loaded syringes and typically made of glass. Pre-filled autoinjectors are used for intramuscular administration of medication with a high degree of dispersion. Pre-filled auto-injector offers varying needle length, spring force & needle gauge. Pre-Filled Auto-Injectors market offers a convenient alternative to traditional subcutaneous injections. It increases patient compliance and adherence during the treatment of various indications. The advantages of pre-filled auto-injectors over the traditional injections have boosted the growth of the market. Further, technological advancements have led to the development of fully automatic injectors with higher patient convenience. Pre-filled auto-injectors are proven reliable, safe and decrease the dose errors. Along with this, changing regulations to control the dose errors have to lead to the rapid growth of pre-filled auto-injectors market. Additionally, they have a wide range of applications in treating autoimmune disorders which further boosted the burgeoning growth of pre-filled auto-injectors market. Other factors like changing socio-demographics and increasing awareness among the general population have created the potential growth of global pre-filled auto-injectors market. North America Pre-Filled Auto-Injectors market is a major shareholder in the global market due to high penetration among the general population. Europe & Asia Pacific regions are expected to witness the highest growth rate in global pre-filled auto-injectors. Latin America and Rest of world Pre-Filled Auto-Injectors markets are expected to account small share in global Pre-Filled Auto-Injectors market due to less adoption. Pre-Filled Auto-Injectors market players include Mylan N.V., Amedra Pharmaceuticals LLC, Owen Mumford, Ypsomed AG, Antares Pharma, SHL Group, Johnson & Johnson, Becton, Dickinson and Company, Pfizer Inc., Eli Lilly and Company. Manufacturers are majorly focused on investing in R&D to strengthen the product portfolio of the market. Pre-Filled Auto Injectors Market Segmentation: By Product Type Reusable Auto Injectors Single Use Auto-injector By Material Type Glass Plastic By Sales Channel Retail Pharmacies Institutional Distribution Online Pharmacies By Region Europe North America APAC Latin America Rest of World Competitive Landscape: Tier 1 players- established companies in the market with major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways: Growth prospects SWOT analysis Key trends Key datapoints affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global market on the basis of product type, sales channel and region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and overall market To predict market size, in five key regions (along with countries)—North America, Europe, Asia Pacific, and Latin America To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Pre-filled auto-injectors are defined as unit dose medication for parenteral administration. Pre-filled auto-injectors are intended for self-administration by patients. Pre-filled auto-injectors are mostly spring-loaded syringes and typically made of glass. Pre-filled autoinjectors are used for intramuscular administration of medication with a high degree of dispersion. Pre-filled auto-injector offers varying needle length, spring force & needle gauge.
Pre-Filled Auto-Injectors market offers a convenient alternative to traditional subcutaneous injections. It increases patient compliance and adherence during the treatment of various indications. The advantages of pre-filled auto-injectors over the traditional injections have boosted the growth of the market. Further, technological advancements have led to the development of fully automatic injectors with higher patient convenience. Pre-filled auto-injectors are proven reliable, safe and decrease the dose errors. Along with this, changing regulations to control the dose errors have to lead to the rapid growth of pre-filled auto-injectors market. Additionally, they have a wide range of applications in treating autoimmune disorders which further boosted the burgeoning growth of pre-filled auto-injectors market. Other factors like changing socio-demographics and increasing awareness among the general population have created the potential growth of global pre-filled auto-injectors market.
North America Pre-Filled Auto-Injectors market is a major shareholder in the global market due to high penetration among the general population. Europe & Asia Pacific regions are expected to witness the highest growth rate in global pre-filled auto-injectors. Latin America and Rest of world Pre-Filled Auto-Injectors markets are expected to account small share in global Pre-Filled Auto-Injectors market due to less adoption.
Pre-Filled Auto-Injectors market players include Mylan N.V., Amedra Pharmaceuticals LLC, Owen Mumford, Ypsomed AG, Antares Pharma, SHL Group, Johnson & Johnson, Becton, Dickinson and Company, Pfizer Inc., Eli Lilly and Company. Manufacturers are majorly focused on investing in R&D to strengthen the product portfolio of the market.
Pre-Filled Auto Injectors Market Segmentation:
By Product Type
By Material Type
By Sales Channel
By Region
Competitive Landscape:
FutureWise Takeaways:
Objectives of the Study:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Pre-Filled Auto Injectors Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Pre-Filled Auto Injectors Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Pre-Filled Auto Injectors Market By Product Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Reusable Auto Injectors 7.2. Single Use Auto-injector 8. Global Pre-Filled Auto Injectors Market By Material Type Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Glass 8.2. Plastic 9. Global Pre-Filled Auto Injectors Market By Sales Channel Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Retail Pharmacies 9.2. Institutional Distribution 9.3. Online Pharmacies 10.North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) along with expected regulatory needs 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027 11. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Switzerland 11.2.9. Rest of Western Europe 12. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) - along with expected regulatory needs 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Japan 12.2.2. China 12.2.3. Singapore 12.2.4. India 12.2.5. Australia and New Zealand 12.2.6. ASEAN 12.2.7. South Korea 12.2.8. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 13. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Regional Market Trends 13.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.3.1. Brazil 13.3.2. Venezuela 13.3.3. Argentina 13.3.4. Rest of Latin America 13.4. Market Size (USD Million) Forecast for Latin America 2020-2027 14. Rest of World Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 15.1. Mylan N.V. 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Amedra Pharmaceuticals LLC 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Owen Mumford 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Ypsomed AG 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. Antares Pharma 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. SHL Group 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Johnson & Johnson 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Antares Pharma 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. SHL Group 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Johnson & Johnson 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 16. FutureWise SME key takeaway points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics